Literature DB >> 18266013

Activities of artesunate and amodiaquine against intestinal helminth in children with Plasmodium falciparum malaria in endemic areas.

A A Adedeji1, F A Fehintola, N O Olasupo, T Balogun, A Sowunmi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266013     DOI: 10.1007/s10096-008-0464-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  6 in total

Review 1.  Global epidemiology, ecology and control of soil-transmitted helminth infections.

Authors:  S Brooker; A C A Clements; D A P Bundy
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

Review 2.  Artemether, an effective new agent for chemoprophylaxis against shistosomiasis in China: its in vivo effect on the biochemical metabolism of the Asian schistosome.

Authors:  X Shuhua; P J Hotez; M Tanner
Journal:  Southeast Asian J Trop Med Public Health       Date:  2000-12       Impact factor: 0.267

3.  Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1973

Review 4.  The public health impact of chloroquine resistance in Africa.

Authors:  J F Trape
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

5.  Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial.

Authors:  M Adjuik; P Agnamey; A Babiker; S Borrmann; P Brasseur; M Cisse; F Cobelens; S Diallo; J F Faucher; P Garner; S Gikunda; P G Kremsner; S Krishna; B Lell; M Loolpapit; P B Matsiegui; M A Missinou; J Mwanza; F Ntoumi; P Olliaro; P Osimbo; P Rezbach; E Some; W R J Taylor
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

6.  Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria.

Authors:  Peter J Hotez; David H Molyneux; Alan Fenwick; Eric Ottesen; Sonia Ehrlich Sachs; Jeffrey D Sachs
Journal:  PLoS Med       Date:  2006-01       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.